Dr. Cheville is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511- Is this information wrong?
Summary
- Dr. John Cheville is a pathologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He received his medical degree from University of Iowa Carver College of Medicine and has been in practice 27 years. He specializes in surgical pathology, molecular pathology and urologic pathology.
Education & Training
- University of Iowa Hospitals and ClinicsResidency, Pathology-Anatomic and Clinical, 1991 - 1994
- Western Michigan University Homer Stryker MD School of MedicineInternship, Transitional Year, 1990 - 1991
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1990
Certifications & Licensure
- MN State Medical License 1994 - 2024
- WI State Medical License 1995 - 2011
- MI State Medical License 1990 - 1991
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- Diagnostic pitfalls: Florid mesothelial hyperplasia and mesothelioma of the tunica vaginalis.Sounak Gupta, J Kenneth Schoolmeester, John C Cheville> ;Human Pathology. 2024 Apr 28
- Expanding the spectrum of paratesticular mullerian-origin tumors: Adenocarcinoma with mixed serous and endometrioid features and clear cell carcinoma.Sounak Gupta, J Kenneth Schoolmeester, John C Cheville> ;Human Pathology. 2024 Apr 27
- ALK-rearranged renal cell carcinoma with nuclear mitotic apparatus protein 1 (NUMA1) as a fusion partner.Sounak Gupta, Murli Krishna, John C Cheville> ;Human Pathology. 2024 Apr 24
- Join now to see all
Journal Articles
- Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 EncephalitisDivyanshu Dubey, John Cheville, Thomas Kryzer, Chadwick Hales, Jorge Kattah, Eoin P Flanagan, Anastasia Zekeridou, Jenny J Linnoila, Andrew Mckeon, Sean J Pittock, JAMA Neurology
- The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and TreatmentBimal Bhindi, Igor Frank, Aaron M Potretzke, Stephen A Boorjian, John C Cheville, Bradley C Leibovich, European Urology
Authored Content
- Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 EncephalitisAugust 2020
- Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 EncephalitisAugust 2020
Press Mentions
- Team Discovers Biological Markers That Could Guide Treatment for Prostate CancerJanuary 3rd, 2019
- Targeting Cancer: Mayo Clinic Radio Health MinuteApril 21st, 2017
- Scientists Propose Breast Cancer Drug for Bladder Cancer PatientsJanuary 21st, 2014
- Join now to see all
Grant Support
- Biospecimens CoreNational Cancer Institute2008–2010
- Core--Tissue ProcurementNational Cancer Institute2001–2002
Hospital Affiliations
- Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: